Page 3 - Lon Sln News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lon sln. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lon Sln Today - Breaking & Trending Today
28 April 2021 | 09:20am StockMarketWire.com - RNA-based therapy developer Silence Therapeutics said it had achieved another research milestone as part of an ongoing collaboration with Mallinckrodt for complement-mediated diseases. Reaching the milestone had triggeed a further $2.0 million payment to Silence. The milestone related to pre-clinical development work on the SLN500 C3 targeting program. Silence said it continued to work with Mallinckrodt to progress investigational new drug enabling studies for SLN501, the first nominated product candidate in the SLN500 program, this year. At 9:20am: [LON:SLN] Silence Therapeutics PLC share price was 0p at 455p Story provided by StockMarketWire.com Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. ....